Novant Health Cancer Institute is a clinical research site located in Charlotte, North Carolina, United States 28204.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Novant Health Cancer Institute has participated in 8 clinical trials with 4 currently active.
Therapeutic areas: Cervical Cancer, HER2-positive Solid Cancers, Chemoradiotherapy-Induced Severe Oral Mucositis.
Sponsors: GOG Foundation, Molecular Templates, Inc., Monopar Therapeutics.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Novant Health Cancer Institute has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novant Health Cancer Institute has 8 clinical trials on record, with 4 currently active. Their work covers Cervical Cancer, HER2-positive Solid Cancers, Chemoradiotherapy-Induced Severe Oral Mucositis.
Yes — Novant Health Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.